Our Mission
The Oxford Vaccine Group has been at the forefront of vaccine development for 30 years, helping to fight diseases of major global importance through research and education around the world.
What's Happening?
30 Years of OVG
1994 - 2024
Join our celebrations and learn about 30 years of ground-breaking research at OVG
Study Spotlight
Be a Vaccine Hero
Take part in a study
Could you be a Vaccine Hero by taking part in one of our clinical trials? Find out about the trials and studies currently looking for volunteers, as well as what it is like taking part from previous participants
Study - LEGACY02
A study examining lymph node cells to assess how age affects immune responses to a new vaccine.
Study - PCV15-PCV20
A study which will guide decisions on future changes to the routine UK immunisation schedule.
Study - BIO-006
Understanding about relapsing malaria infections caused by Plasmodium vivax
Research at OVG
Education, Learning and Public Involvement
Latest Publications
⠀⠀⠀⠀⠀
-
Loi MV. et al, (2025), Crit Care Explor, 7
-
Abu-Helalah M. et al, (2025), Viruses, 17, 170 - 170
-
Hao S. et al, (2025), bioRxiv
-
Mass testing for discovery and control of COVID-19 outbreaks in adult social care: an observational study and cost-effectiveness analysis of 14,805 care homes in England
Lambert BEN. et al, (2025), BMJ Public Health
Working Together
National Immunisation Schedule Evaluation Consortium II
OVG is proud to lead NISEC II, a collaboration between a network of Academic Clinical Research groups and the UK Health Security Agency.
Immune Memory and Mechanisms of Protection from Vaccines
Oxford is proud to host the IMMPROVE consortium of universities, government, industry and others.